Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
The facility will manufacture its Herceptin biosimilar, Tuznue
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
The company will manufacture a cancer immunotherapy product from 2022
Subscribe To Our Newsletter & Stay Updated
